Key result
Omega-3 supplementation lowers serum BMP-4 vs. placebo in men with CAD.
Why the study?
BMP-4, ox-LDL, and YKL-40 are potential inflammatory biomarkers in CAD, and the effects of omega-3 supplementation on their serum levels were unclear.
Does omega-3 supplementation reduce serum YKL-40, BMP-4, and ox-LDL levels in men with coronary artery disease?
RCT (n=42)
Double-blind
Permuted block randomization (block size 4)
No
Does omega-3 supplementation reduce serum YKL-40, BMP-4, and ox-LDL levels in men with coronary artery disease?
Omega-3 fatty acid supplementation for 8 weeks significantly reduced serum levels of inflammatory and atherogenic biomarkers (BMP-4, YKL-40, and ox-LDL) in men with coronary artery disease.
Answers are grounded in this paper and cite their sources.
Omega-3 supplementation lowers BMP-4 in men with CAD; extends anti-inflammatory evidence and supports outcome trials.
Objective: Bone morphogenic protein-4 (BMP-4), oxidized low density lipoprotein (ox-LDL), and YKL-40 are the potential biomarkers which may causes inflammation and cardiovascular disease. Omega-3 fatty acid-rich diets may have anti-inflammatory effects. This study was designed to determine the effects of omega-3 fatty acid supplementation on serum YKL-40, BMP-4, and ox-LDL levels in men with coronary artery disease (CAD). Methods: The current study was a randomized, placebo-controlled, double-blind parallel-group clinical trial that involved 42 male patients with CAD. The volunteers were randomly allocated into two groups to receive 4 g omega-3 (containing 720 mg EPA plus 480 mg DHA) supplements (n = 21) or placebo (n = 21) per day for 8 weeks. Fasting blood samples were taken at the beginning and end of the trial to quantify serum levels of ox-LDL, YKL-40 and BMP-4 concentrations. Result: The results identified that omega-3 fatty acid supplementation for 8 weeks had a noticeable effect on serum ox-LDL (P = 0.03), YKL-40 (P = 0.01), and BMP-4 (P = 0.01) concentrations between groups. A significant difference was found between placebo and omega-3 supplementation groups only for BMP-4 (P = 0.046) after removing counfounding effects of vitamin C and carbohydrates. Conclusions: The results of this study indicate that omega-3 supplementation decreased serum BMP-4 significantly. Serum YKL-40 correlated with ox-LDL before intervention. Further study is recommended to elucidate the exact mechanisms for this process.
No takes yet. Share an insight, caveat, or question.
Samavat et al. (2019) conducted an RCT in Coronary artery disease (n=42). Omega-3 fatty acid vs. Placebo (4 g edible paraffin) was evaluated on Change in serum BMP-4 concentration (ng/ml) (p=0.046). Omega-3 fatty acid supplementation for 8 weeks significantly decreased serum BMP-4 concentrations compared to placebo in men with coronary artery disease.
Synapse has enriched 10 related papers. Consider them for comparative context: